nodes	percent_of_prediction	percent_of_DWPC	metapath
Estropipate—CYP3A4—Everolimus—kidney cancer	0.0731	0.14	CbGbCtD
Estropipate—ALB—Erlotinib—kidney cancer	0.0591	0.113	CbGbCtD
Estropipate—CYP1A2—Pazopanib—kidney cancer	0.0495	0.0945	CbGbCtD
Estropipate—CYP3A4—Temsirolimus—kidney cancer	0.0494	0.0943	CbGbCtD
Estropipate—CYP2C9—Capecitabine—kidney cancer	0.0465	0.0888	CbGbCtD
Estropipate—CYP1A2—Erlotinib—kidney cancer	0.0353	0.0674	CbGbCtD
Estropipate—CYP2C9—Paclitaxel—kidney cancer	0.0291	0.0556	CbGbCtD
Estropipate—CYP1A2—Sorafenib—kidney cancer	0.0287	0.0548	CbGbCtD
Estropipate—CYP3A4—Pazopanib—kidney cancer	0.0259	0.0495	CbGbCtD
Estropipate—CYP2C9—Sorafenib—kidney cancer	0.0259	0.0494	CbGbCtD
Estropipate—CYP3A4—Erlotinib—kidney cancer	0.0185	0.0353	CbGbCtD
Estropipate—CYP3A4—Paclitaxel—kidney cancer	0.0169	0.0323	CbGbCtD
Estropipate—CYP3A4—Sorafenib—kidney cancer	0.0151	0.0287	CbGbCtD
Estropipate—CYP3A4—Vinblastine—kidney cancer	0.0149	0.0284	CbGbCtD
Estropipate—CYP3A4—Vincristine—kidney cancer	0.0146	0.0279	CbGbCtD
Estropipate—CYP3A4—Sunitinib—kidney cancer	0.0122	0.0233	CbGbCtD
Estropipate—CYP3A4—Doxorubicin—kidney cancer	0.00913	0.0174	CbGbCtD
Estropipate—CYP1A2—urine—kidney cancer	0.00211	0.15	CbGeAlD
Estropipate—CYP2C9—urine—kidney cancer	0.002	0.142	CbGeAlD
Estropipate—CYP3A4—urine—kidney cancer	0.00152	0.108	CbGeAlD
Estropipate—ESR2—renal system—kidney cancer	0.000976	0.0695	CbGeAlD
Estropipate—ESR2—kidney—kidney cancer	0.000944	0.0672	CbGeAlD
Estropipate—ESR2—gonad—kidney cancer	0.000875	0.0623	CbGeAlD
Estropipate—SHBG—gonad—kidney cancer	0.000851	0.0606	CbGeAlD
Estropipate—SLC22A1—renal system—kidney cancer	0.000819	0.0583	CbGeAlD
Estropipate—SLC22A1—kidney—kidney cancer	0.000791	0.0563	CbGeAlD
Estropipate—ESR1—renal system—kidney cancer	0.000669	0.0476	CbGeAlD
Estropipate—ESR1—kidney—kidney cancer	0.000646	0.046	CbGeAlD
Estropipate—ESR1—gonad—kidney cancer	0.0006	0.0427	CbGeAlD
Estropipate—CYP1A2—renal system—kidney cancer	0.000515	0.0367	CbGeAlD
Estropipate—Estriol—ABCB1—kidney cancer	0.000459	0.186	CrCbGaD
Estropipate—Estramustine—ABCB1—kidney cancer	0.000426	0.173	CrCbGaD
Estropipate—Estrone—CYP1A1—kidney cancer	0.000411	0.167	CrCbGaD
Estropipate—CYP3A4—renal system—kidney cancer	0.000373	0.0265	CbGeAlD
Estropipate—CYP3A4—kidney—kidney cancer	0.000361	0.0257	CbGeAlD
Estropipate—Estradiol—CYP1A1—kidney cancer	0.000311	0.127	CrCbGaD
Estropipate—Ethinyl Estradiol—ABCB1—kidney cancer	0.000251	0.102	CrCbGaD
Estropipate—Infection—Gemcitabine—kidney cancer	0.000221	0.000624	CcSEcCtD
Estropipate—Back pain—Paclitaxel—kidney cancer	0.000221	0.000623	CcSEcCtD
Estropipate—Dizziness—Vinblastine—kidney cancer	0.00022	0.000622	CcSEcCtD
Estropipate—Dizziness—Everolimus—kidney cancer	0.000219	0.00062	CcSEcCtD
Estropipate—Muscle spasms—Paclitaxel—kidney cancer	0.000219	0.00062	CcSEcCtD
Estropipate—Abdominal pain—Sunitinib—kidney cancer	0.000219	0.000619	CcSEcCtD
Estropipate—Body temperature increased—Sunitinib—kidney cancer	0.000219	0.000619	CcSEcCtD
Estropipate—Diarrhoea—Erlotinib—kidney cancer	0.000219	0.000619	CcSEcCtD
Estropipate—Conjugated Estrogens—ABCB1—kidney cancer	0.000219	0.089	CrCbGaD
Estropipate—Estrone—ABCB1—kidney cancer	0.000218	0.0887	CrCbGaD
Estropipate—Nervous system disorder—Gemcitabine—kidney cancer	0.000218	0.000616	CcSEcCtD
Estropipate—Skin disorder—Gemcitabine—kidney cancer	0.000216	0.00061	CcSEcCtD
Estropipate—Rhinitis—Capecitabine—kidney cancer	0.000215	0.000609	CcSEcCtD
Estropipate—Gastrointestinal pain—Dactinomycin—kidney cancer	0.000214	0.000606	CcSEcCtD
Estropipate—Musculoskeletal discomfort—Vincristine—kidney cancer	0.000213	0.000603	CcSEcCtD
Estropipate—Pharyngitis—Capecitabine—kidney cancer	0.000213	0.000603	CcSEcCtD
Estropipate—Hypersensitivity—Sorafenib—kidney cancer	0.000212	0.000599	CcSEcCtD
Estropipate—Insomnia—Vincristine—kidney cancer	0.000212	0.000599	CcSEcCtD
Estropipate—Oedema peripheral—Capecitabine—kidney cancer	0.000212	0.000598	CcSEcCtD
Estropipate—Vomiting—Vinblastine—kidney cancer	0.000212	0.000598	CcSEcCtD
Estropipate—Dizziness—Erlotinib—kidney cancer	0.000212	0.000598	CcSEcCtD
Estropipate—Vomiting—Everolimus—kidney cancer	0.000211	0.000596	CcSEcCtD
Estropipate—Paraesthesia—Vincristine—kidney cancer	0.00021	0.000595	CcSEcCtD
Estropipate—Dermatitis bullous—Doxorubicin—kidney cancer	0.00021	0.000592	CcSEcCtD
Estropipate—Rash—Everolimus—kidney cancer	0.000209	0.000591	CcSEcCtD
Estropipate—Dermatitis—Everolimus—kidney cancer	0.000209	0.00059	CcSEcCtD
Estropipate—Headache—Vinblastine—kidney cancer	0.000209	0.000589	CcSEcCtD
Estropipate—Angioedema—Paclitaxel—kidney cancer	0.000208	0.000589	CcSEcCtD
Estropipate—Purpura—Doxorubicin—kidney cancer	0.000208	0.000587	CcSEcCtD
Estropipate—Headache—Everolimus—kidney cancer	0.000208	0.000587	CcSEcCtD
Estropipate—Body temperature increased—Dactinomycin—kidney cancer	0.000207	0.000586	CcSEcCtD
Estropipate—Abdominal pain—Dactinomycin—kidney cancer	0.000207	0.000586	CcSEcCtD
Estropipate—Visual impairment—Capecitabine—kidney cancer	0.000207	0.000585	CcSEcCtD
Estropipate—Anaphylactoid reaction—Doxorubicin—kidney cancer	0.000207	0.000585	CcSEcCtD
Estropipate—Asthenia—Sorafenib—kidney cancer	0.000207	0.000584	CcSEcCtD
Estropipate—Vertigo—Paclitaxel—kidney cancer	0.000205	0.000579	CcSEcCtD
Estropipate—Cerebrovascular accident—Doxorubicin—kidney cancer	0.000204	0.000578	CcSEcCtD
Estropipate—Hypersensitivity—Sunitinib—kidney cancer	0.000204	0.000577	CcSEcCtD
Estropipate—Pruritus—Sorafenib—kidney cancer	0.000204	0.000576	CcSEcCtD
Estropipate—Vomiting—Erlotinib—kidney cancer	0.000203	0.000575	CcSEcCtD
Estropipate—Erythema multiforme—Capecitabine—kidney cancer	0.000203	0.000574	CcSEcCtD
Estropipate—Musculoskeletal discomfort—Gemcitabine—kidney cancer	0.000203	0.000572	CcSEcCtD
Estropipate—Gastrointestinal disorder—Vincristine—kidney cancer	0.000202	0.000572	CcSEcCtD
Estropipate—Fatigue—Vincristine—kidney cancer	0.000202	0.000571	CcSEcCtD
Estropipate—Rash—Erlotinib—kidney cancer	0.000202	0.00057	CcSEcCtD
Estropipate—Dermatitis—Erlotinib—kidney cancer	0.000202	0.00057	CcSEcCtD
Estropipate—Palpitations—Paclitaxel—kidney cancer	0.000201	0.000569	CcSEcCtD
Estropipate—Insomnia—Gemcitabine—kidney cancer	0.000201	0.000568	CcSEcCtD
Estropipate—Eye disorder—Capecitabine—kidney cancer	0.000201	0.000568	CcSEcCtD
Estropipate—Headache—Erlotinib—kidney cancer	0.0002	0.000566	CcSEcCtD
Estropipate—Constipation—Vincristine—kidney cancer	0.0002	0.000566	CcSEcCtD
Estropipate—Pain—Vincristine—kidney cancer	0.0002	0.000566	CcSEcCtD
Estropipate—Pain in extremity—Doxorubicin—kidney cancer	0.0002	0.000566	CcSEcCtD
Estropipate—Paraesthesia—Gemcitabine—kidney cancer	0.0002	0.000564	CcSEcCtD
Estropipate—Cardiac disorder—Capecitabine—kidney cancer	0.000199	0.000564	CcSEcCtD
Estropipate—Cough—Paclitaxel—kidney cancer	0.000199	0.000562	CcSEcCtD
Estropipate—Asthenia—Sunitinib—kidney cancer	0.000199	0.000562	CcSEcCtD
Estropipate—Nausea—Vinblastine—kidney cancer	0.000198	0.000559	CcSEcCtD
Estropipate—Somnolence—Gemcitabine—kidney cancer	0.000198	0.000558	CcSEcCtD
Estropipate—Migraine—Doxorubicin—kidney cancer	0.000197	0.000557	CcSEcCtD
Estropipate—Nausea—Everolimus—kidney cancer	0.000197	0.000557	CcSEcCtD
Estropipate—Diarrhoea—Sorafenib—kidney cancer	0.000197	0.000557	CcSEcCtD
Estropipate—Pruritus—Sunitinib—kidney cancer	0.000196	0.000554	CcSEcCtD
Estropipate—Angiopathy—Capecitabine—kidney cancer	0.000195	0.000551	CcSEcCtD
Estropipate—Immune system disorder—Capecitabine—kidney cancer	0.000194	0.000549	CcSEcCtD
Estropipate—Arthralgia—Paclitaxel—kidney cancer	0.000194	0.000549	CcSEcCtD
Estropipate—Myalgia—Paclitaxel—kidney cancer	0.000194	0.000549	CcSEcCtD
Estropipate—Mediastinal disorder—Capecitabine—kidney cancer	0.000194	0.000547	CcSEcCtD
Estropipate—Anxiety—Paclitaxel—kidney cancer	0.000193	0.000547	CcSEcCtD
Estropipate—Hypersensitivity—Dactinomycin—kidney cancer	0.000193	0.000546	CcSEcCtD
Estropipate—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	0.000193	0.000545	CcSEcCtD
Estropipate—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000192	0.000542	CcSEcCtD
Estropipate—Fatigue—Gemcitabine—kidney cancer	0.000192	0.000542	CcSEcCtD
Estropipate—Gastrointestinal pain—Vincristine—kidney cancer	0.000192	0.000541	CcSEcCtD
Estropipate—Dizziness—Sorafenib—kidney cancer	0.00019	0.000538	CcSEcCtD
Estropipate—Pain—Gemcitabine—kidney cancer	0.00019	0.000537	CcSEcCtD
Estropipate—Constipation—Gemcitabine—kidney cancer	0.00019	0.000537	CcSEcCtD
Estropipate—Nausea—Erlotinib—kidney cancer	0.00019	0.000537	CcSEcCtD
Estropipate—Alopecia—Capecitabine—kidney cancer	0.00019	0.000537	CcSEcCtD
Estropipate—Mood swings—Doxorubicin—kidney cancer	0.00019	0.000536	CcSEcCtD
Estropipate—Diarrhoea—Sunitinib—kidney cancer	0.00019	0.000536	CcSEcCtD
Estropipate—Mental disorder—Capecitabine—kidney cancer	0.000188	0.000532	CcSEcCtD
Estropipate—Asthenia—Dactinomycin—kidney cancer	0.000188	0.000532	CcSEcCtD
Estropipate—Erythema—Capecitabine—kidney cancer	0.000187	0.000529	CcSEcCtD
Estropipate—Malnutrition—Capecitabine—kidney cancer	0.000187	0.000529	CcSEcCtD
Estropipate—Anaphylactic shock—Paclitaxel—kidney cancer	0.000186	0.000526	CcSEcCtD
Estropipate—Oedema—Paclitaxel—kidney cancer	0.000186	0.000526	CcSEcCtD
Estropipate—Abdominal pain—Vincristine—kidney cancer	0.000185	0.000523	CcSEcCtD
Estropipate—Body temperature increased—Vincristine—kidney cancer	0.000185	0.000523	CcSEcCtD
Estropipate—Infection—Paclitaxel—kidney cancer	0.000185	0.000522	CcSEcCtD
Estropipate—Flatulence—Capecitabine—kidney cancer	0.000184	0.000521	CcSEcCtD
Estropipate—Dizziness—Sunitinib—kidney cancer	0.000183	0.000518	CcSEcCtD
Estropipate—Vomiting—Sorafenib—kidney cancer	0.000183	0.000517	CcSEcCtD
Estropipate—Nervous system disorder—Paclitaxel—kidney cancer	0.000182	0.000516	CcSEcCtD
Estropipate—Rash—Sorafenib—kidney cancer	0.000182	0.000513	CcSEcCtD
Estropipate—Dermatitis—Sorafenib—kidney cancer	0.000181	0.000512	CcSEcCtD
Estropipate—Back pain—Capecitabine—kidney cancer	0.000181	0.000511	CcSEcCtD
Estropipate—Breast disorder—Doxorubicin—kidney cancer	0.000181	0.000511	CcSEcCtD
Estropipate—Skin disorder—Paclitaxel—kidney cancer	0.000181	0.000511	CcSEcCtD
Estropipate—Headache—Sorafenib—kidney cancer	0.00018	0.00051	CcSEcCtD
Estropipate—Muscle spasms—Capecitabine—kidney cancer	0.00018	0.000508	CcSEcCtD
Estropipate—Diarrhoea—Dactinomycin—kidney cancer	0.000179	0.000507	CcSEcCtD
Estropipate—Vomiting—Sunitinib—kidney cancer	0.000176	0.000498	CcSEcCtD
Estropipate—Body temperature increased—Gemcitabine—kidney cancer	0.000176	0.000497	CcSEcCtD
Estropipate—Rash—Sunitinib—kidney cancer	0.000175	0.000494	CcSEcCtD
Estropipate—Dermatitis—Sunitinib—kidney cancer	0.000174	0.000493	CcSEcCtD
Estropipate—Abdominal distension—Doxorubicin—kidney cancer	0.000174	0.000492	CcSEcCtD
Estropipate—Headache—Sunitinib—kidney cancer	0.000174	0.00049	CcSEcCtD
Estropipate—Influenza—Doxorubicin—kidney cancer	0.000173	0.000489	CcSEcCtD
Estropipate—Asthma—Doxorubicin—kidney cancer	0.000173	0.000489	CcSEcCtD
Estropipate—Hypersensitivity—Vincristine—kidney cancer	0.000173	0.000488	CcSEcCtD
Estropipate—Nausea—Sorafenib—kidney cancer	0.000171	0.000483	CcSEcCtD
Estropipate—Pancreatitis—Doxorubicin—kidney cancer	0.00017	0.00048	CcSEcCtD
Estropipate—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.00017	0.000479	CcSEcCtD
Estropipate—Insomnia—Paclitaxel—kidney cancer	0.000168	0.000476	CcSEcCtD
Estropipate—Vertigo—Capecitabine—kidney cancer	0.000168	0.000475	CcSEcCtD
Estropipate—Asthenia—Vincristine—kidney cancer	0.000168	0.000475	CcSEcCtD
Estropipate—Paraesthesia—Paclitaxel—kidney cancer	0.000167	0.000472	CcSEcCtD
Estropipate—Vomiting—Dactinomycin—kidney cancer	0.000167	0.000471	CcSEcCtD
Estropipate—Somnolence—Paclitaxel—kidney cancer	0.000165	0.000468	CcSEcCtD
Estropipate—Estradiol—ABCB1—kidney cancer	0.000165	0.0672	CrCbGaD
Estropipate—Palpitations—Capecitabine—kidney cancer	0.000165	0.000467	CcSEcCtD
Estropipate—Rash—Dactinomycin—kidney cancer	0.000165	0.000467	CcSEcCtD
Estropipate—Nausea—Sunitinib—kidney cancer	0.000165	0.000465	CcSEcCtD
Estropipate—Dyspepsia—Paclitaxel—kidney cancer	0.000164	0.000463	CcSEcCtD
Estropipate—Cough—Capecitabine—kidney cancer	0.000163	0.000461	CcSEcCtD
Estropipate—Dysuria—Doxorubicin—kidney cancer	0.000162	0.000457	CcSEcCtD
Estropipate—Upper respiratory tract infection—Doxorubicin—kidney cancer	0.000161	0.000455	CcSEcCtD
Estropipate—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000161	0.000454	CcSEcCtD
Estropipate—Fatigue—Paclitaxel—kidney cancer	0.00016	0.000453	CcSEcCtD
Estropipate—Diarrhoea—Vincristine—kidney cancer	0.00016	0.000453	CcSEcCtD
Estropipate—Asthenia—Gemcitabine—kidney cancer	0.000159	0.000451	CcSEcCtD
Estropipate—Arthralgia—Capecitabine—kidney cancer	0.000159	0.00045	CcSEcCtD
Estropipate—Myalgia—Capecitabine—kidney cancer	0.000159	0.00045	CcSEcCtD
Estropipate—Constipation—Paclitaxel—kidney cancer	0.000159	0.00045	CcSEcCtD
Estropipate—Pain—Paclitaxel—kidney cancer	0.000159	0.00045	CcSEcCtD
Estropipate—Anxiety—Capecitabine—kidney cancer	0.000159	0.000449	CcSEcCtD
Estropipate—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	0.000158	0.000447	CcSEcCtD
Estropipate—Weight increased—Doxorubicin—kidney cancer	0.000158	0.000445	CcSEcCtD
Estropipate—Pruritus—Gemcitabine—kidney cancer	0.000157	0.000444	CcSEcCtD
Estropipate—Hyperglycaemia—Doxorubicin—kidney cancer	0.000156	0.000441	CcSEcCtD
Estropipate—Nausea—Dactinomycin—kidney cancer	0.000156	0.00044	CcSEcCtD
Estropipate—Dizziness—Vincristine—kidney cancer	0.000155	0.000438	CcSEcCtD
Estropipate—Infestation—Doxorubicin—kidney cancer	0.000154	0.000436	CcSEcCtD
Estropipate—Infestation NOS—Doxorubicin—kidney cancer	0.000154	0.000436	CcSEcCtD
Estropipate—Oedema—Capecitabine—kidney cancer	0.000153	0.000432	CcSEcCtD
Estropipate—Gastrointestinal pain—Paclitaxel—kidney cancer	0.000152	0.00043	CcSEcCtD
Estropipate—Diarrhoea—Gemcitabine—kidney cancer	0.000152	0.00043	CcSEcCtD
Estropipate—Infection—Capecitabine—kidney cancer	0.000152	0.000429	CcSEcCtD
Estropipate—Neuropathy peripheral—Doxorubicin—kidney cancer	0.000151	0.000428	CcSEcCtD
Estropipate—Nervous system disorder—Capecitabine—kidney cancer	0.00015	0.000423	CcSEcCtD
Estropipate—Vomiting—Vincristine—kidney cancer	0.000149	0.000421	CcSEcCtD
Estropipate—Skin disorder—Capecitabine—kidney cancer	0.000148	0.000419	CcSEcCtD
Estropipate—Urticaria—Paclitaxel—kidney cancer	0.000148	0.000418	CcSEcCtD
Estropipate—Rash—Vincristine—kidney cancer	0.000148	0.000417	CcSEcCtD
Estropipate—Dermatitis—Vincristine—kidney cancer	0.000148	0.000417	CcSEcCtD
Estropipate—Abdominal pain—Paclitaxel—kidney cancer	0.000147	0.000416	CcSEcCtD
Estropipate—Body temperature increased—Paclitaxel—kidney cancer	0.000147	0.000416	CcSEcCtD
Estropipate—Headache—Vincristine—kidney cancer	0.000147	0.000415	CcSEcCtD
Estropipate—Hepatobiliary disease—Doxorubicin—kidney cancer	0.000146	0.000413	CcSEcCtD
Estropipate—Sinusitis—Doxorubicin—kidney cancer	0.000145	0.000409	CcSEcCtD
Estropipate—Vomiting—Gemcitabine—kidney cancer	0.000141	0.000399	CcSEcCtD
Estropipate—Rash—Gemcitabine—kidney cancer	0.00014	0.000396	CcSEcCtD
Estropipate—Dermatitis—Gemcitabine—kidney cancer	0.00014	0.000396	CcSEcCtD
Estropipate—Headache—Gemcitabine—kidney cancer	0.000139	0.000393	CcSEcCtD
Estropipate—Nausea—Vincristine—kidney cancer	0.000139	0.000393	CcSEcCtD
Estropipate—Musculoskeletal discomfort—Capecitabine—kidney cancer	0.000139	0.000393	CcSEcCtD
Estropipate—Rhinitis—Doxorubicin—kidney cancer	0.000139	0.000393	CcSEcCtD
Estropipate—Insomnia—Capecitabine—kidney cancer	0.000138	0.00039	CcSEcCtD
Estropipate—Pharyngitis—Doxorubicin—kidney cancer	0.000138	0.000389	CcSEcCtD
Estropipate—Paraesthesia—Capecitabine—kidney cancer	0.000137	0.000388	CcSEcCtD
Estropipate—Hypersensitivity—Paclitaxel—kidney cancer	0.000137	0.000387	CcSEcCtD
Estropipate—Oedema peripheral—Doxorubicin—kidney cancer	0.000136	0.000386	CcSEcCtD
Estropipate—Dyspepsia—Capecitabine—kidney cancer	0.000134	0.00038	CcSEcCtD
Estropipate—Visual impairment—Doxorubicin—kidney cancer	0.000134	0.000377	CcSEcCtD
Estropipate—Asthenia—Paclitaxel—kidney cancer	0.000134	0.000377	CcSEcCtD
Estropipate—Nausea—Gemcitabine—kidney cancer	0.000132	0.000373	CcSEcCtD
Estropipate—Gastrointestinal disorder—Capecitabine—kidney cancer	0.000132	0.000373	CcSEcCtD
Estropipate—Fatigue—Capecitabine—kidney cancer	0.000132	0.000372	CcSEcCtD
Estropipate—Pruritus—Paclitaxel—kidney cancer	0.000132	0.000372	CcSEcCtD
Estropipate—Erythema multiforme—Doxorubicin—kidney cancer	0.000131	0.00037	CcSEcCtD
Estropipate—Pain—Capecitabine—kidney cancer	0.000131	0.000369	CcSEcCtD
Estropipate—Constipation—Capecitabine—kidney cancer	0.000131	0.000369	CcSEcCtD
Estropipate—Eye disorder—Doxorubicin—kidney cancer	0.000129	0.000366	CcSEcCtD
Estropipate—Cardiac disorder—Doxorubicin—kidney cancer	0.000129	0.000363	CcSEcCtD
Estropipate—Diarrhoea—Paclitaxel—kidney cancer	0.000127	0.00036	CcSEcCtD
Estropipate—Angiopathy—Doxorubicin—kidney cancer	0.000126	0.000355	CcSEcCtD
Estropipate—Immune system disorder—Doxorubicin—kidney cancer	0.000125	0.000354	CcSEcCtD
Estropipate—Gastrointestinal pain—Capecitabine—kidney cancer	0.000125	0.000353	CcSEcCtD
Estropipate—Mediastinal disorder—Doxorubicin—kidney cancer	0.000125	0.000353	CcSEcCtD
Estropipate—Dizziness—Paclitaxel—kidney cancer	0.000123	0.000348	CcSEcCtD
Estropipate—Alopecia—Doxorubicin—kidney cancer	0.000122	0.000346	CcSEcCtD
Estropipate—Mental disorder—Doxorubicin—kidney cancer	0.000121	0.000343	CcSEcCtD
Estropipate—Urticaria—Capecitabine—kidney cancer	0.000121	0.000343	CcSEcCtD
Estropipate—Abdominal pain—Capecitabine—kidney cancer	0.000121	0.000341	CcSEcCtD
Estropipate—Body temperature increased—Capecitabine—kidney cancer	0.000121	0.000341	CcSEcCtD
Estropipate—Erythema—Doxorubicin—kidney cancer	0.000121	0.000341	CcSEcCtD
Estropipate—Malnutrition—Doxorubicin—kidney cancer	0.000121	0.000341	CcSEcCtD
Estropipate—Flatulence—Doxorubicin—kidney cancer	0.000119	0.000336	CcSEcCtD
Estropipate—Tension—Doxorubicin—kidney cancer	0.000118	0.000334	CcSEcCtD
Estropipate—Vomiting—Paclitaxel—kidney cancer	0.000118	0.000334	CcSEcCtD
Estropipate—Rash—Paclitaxel—kidney cancer	0.000117	0.000332	CcSEcCtD
Estropipate—Dermatitis—Paclitaxel—kidney cancer	0.000117	0.000331	CcSEcCtD
Estropipate—Nervousness—Doxorubicin—kidney cancer	0.000117	0.000331	CcSEcCtD
Estropipate—Back pain—Doxorubicin—kidney cancer	0.000117	0.00033	CcSEcCtD
Estropipate—Headache—Paclitaxel—kidney cancer	0.000117	0.000329	CcSEcCtD
Estropipate—Muscle spasms—Doxorubicin—kidney cancer	0.000116	0.000328	CcSEcCtD
Estropipate—Hypersensitivity—Capecitabine—kidney cancer	0.000113	0.000318	CcSEcCtD
Estropipate—Nausea—Paclitaxel—kidney cancer	0.000111	0.000312	CcSEcCtD
Estropipate—Asthenia—Capecitabine—kidney cancer	0.00011	0.00031	CcSEcCtD
Estropipate—Vertigo—Doxorubicin—kidney cancer	0.000108	0.000306	CcSEcCtD
Estropipate—Pruritus—Capecitabine—kidney cancer	0.000108	0.000305	CcSEcCtD
Estropipate—Palpitations—Doxorubicin—kidney cancer	0.000107	0.000301	CcSEcCtD
Estropipate—Cough—Doxorubicin—kidney cancer	0.000105	0.000297	CcSEcCtD
Estropipate—Diarrhoea—Capecitabine—kidney cancer	0.000104	0.000295	CcSEcCtD
Estropipate—Arthralgia—Doxorubicin—kidney cancer	0.000103	0.00029	CcSEcCtD
Estropipate—Myalgia—Doxorubicin—kidney cancer	0.000103	0.00029	CcSEcCtD
Estropipate—Anxiety—Doxorubicin—kidney cancer	0.000102	0.000289	CcSEcCtD
Estropipate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	0.000102	0.000288	CcSEcCtD
Estropipate—Dizziness—Capecitabine—kidney cancer	0.000101	0.000285	CcSEcCtD
Estropipate—Anaphylactic shock—Doxorubicin—kidney cancer	9.84e-05	0.000278	CcSEcCtD
Estropipate—Oedema—Doxorubicin—kidney cancer	9.84e-05	0.000278	CcSEcCtD
Estropipate—Infection—Doxorubicin—kidney cancer	9.78e-05	0.000276	CcSEcCtD
Estropipate—Vomiting—Capecitabine—kidney cancer	9.71e-05	0.000274	CcSEcCtD
Estropipate—Nervous system disorder—Doxorubicin—kidney cancer	9.65e-05	0.000273	CcSEcCtD
Estropipate—Rash—Capecitabine—kidney cancer	9.63e-05	0.000272	CcSEcCtD
Estropipate—Dermatitis—Capecitabine—kidney cancer	9.62e-05	0.000272	CcSEcCtD
Estropipate—Headache—Capecitabine—kidney cancer	9.57e-05	0.00027	CcSEcCtD
Estropipate—Skin disorder—Doxorubicin—kidney cancer	9.56e-05	0.00027	CcSEcCtD
Estropipate—Nausea—Capecitabine—kidney cancer	9.07e-05	0.000256	CcSEcCtD
Estropipate—Musculoskeletal discomfort—Doxorubicin—kidney cancer	8.97e-05	0.000253	CcSEcCtD
Estropipate—Insomnia—Doxorubicin—kidney cancer	8.9e-05	0.000252	CcSEcCtD
Estropipate—Paraesthesia—Doxorubicin—kidney cancer	8.84e-05	0.00025	CcSEcCtD
Estropipate—Somnolence—Doxorubicin—kidney cancer	8.75e-05	0.000247	CcSEcCtD
Estropipate—Dyspepsia—Doxorubicin—kidney cancer	8.67e-05	0.000245	CcSEcCtD
Estropipate—Gastrointestinal disorder—Doxorubicin—kidney cancer	8.5e-05	0.00024	CcSEcCtD
Estropipate—Fatigue—Doxorubicin—kidney cancer	8.49e-05	0.00024	CcSEcCtD
Estropipate—Pain—Doxorubicin—kidney cancer	8.42e-05	0.000238	CcSEcCtD
Estropipate—Constipation—Doxorubicin—kidney cancer	8.42e-05	0.000238	CcSEcCtD
Estropipate—Gastrointestinal pain—Doxorubicin—kidney cancer	8.05e-05	0.000227	CcSEcCtD
Estropipate—Urticaria—Doxorubicin—kidney cancer	7.82e-05	0.000221	CcSEcCtD
Estropipate—Abdominal pain—Doxorubicin—kidney cancer	7.78e-05	0.00022	CcSEcCtD
Estropipate—Body temperature increased—Doxorubicin—kidney cancer	7.78e-05	0.00022	CcSEcCtD
Estropipate—Hypersensitivity—Doxorubicin—kidney cancer	7.25e-05	0.000205	CcSEcCtD
Estropipate—Asthenia—Doxorubicin—kidney cancer	7.06e-05	0.0002	CcSEcCtD
Estropipate—Pruritus—Doxorubicin—kidney cancer	6.96e-05	0.000197	CcSEcCtD
Estropipate—Diarrhoea—Doxorubicin—kidney cancer	6.74e-05	0.00019	CcSEcCtD
Estropipate—Dizziness—Doxorubicin—kidney cancer	6.51e-05	0.000184	CcSEcCtD
Estropipate—Vomiting—Doxorubicin—kidney cancer	6.26e-05	0.000177	CcSEcCtD
Estropipate—Rash—Doxorubicin—kidney cancer	6.21e-05	0.000175	CcSEcCtD
Estropipate—Dermatitis—Doxorubicin—kidney cancer	6.2e-05	0.000175	CcSEcCtD
Estropipate—Headache—Doxorubicin—kidney cancer	6.17e-05	0.000174	CcSEcCtD
Estropipate—Nausea—Doxorubicin—kidney cancer	5.85e-05	0.000165	CcSEcCtD
Estropipate—CYP3A4—Biological oxidations—GSTM1—kidney cancer	4.08e-05	0.000386	CbGpPWpGaD
Estropipate—ALB—Metabolism—FH—kidney cancer	4.06e-05	0.000384	CbGpPWpGaD
Estropipate—ALB—Metabolism—APRT—kidney cancer	4.06e-05	0.000384	CbGpPWpGaD
Estropipate—ALB—Hemostasis—IFNA1—kidney cancer	4.02e-05	0.000381	CbGpPWpGaD
Estropipate—CYP3A4—Metapathway biotransformation—GSTM1—kidney cancer	4.02e-05	0.00038	CbGpPWpGaD
Estropipate—SLC22A1—Transmission across Chemical Synapses—MAPK1—kidney cancer	4e-05	0.000378	CbGpPWpGaD
Estropipate—ESR1—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	3.99e-05	0.000377	CbGpPWpGaD
Estropipate—ESR1—Gene Expression—PSMD7—kidney cancer	3.97e-05	0.000375	CbGpPWpGaD
Estropipate—ALB—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	3.96e-05	0.000375	CbGpPWpGaD
Estropipate—CYP3A4—Biological oxidations—CYP1A1—kidney cancer	3.86e-05	0.000366	CbGpPWpGaD
Estropipate—ESR1—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	3.86e-05	0.000365	CbGpPWpGaD
Estropipate—ALB—Metabolism—GPC3—kidney cancer	3.81e-05	0.000361	CbGpPWpGaD
Estropipate—CYP3A4—Metapathway biotransformation—CYP1A1—kidney cancer	3.81e-05	0.000361	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	3.76e-05	0.000355	CbGpPWpGaD
Estropipate—ALB—Hemostasis—IFNA2—kidney cancer	3.75e-05	0.000354	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—PDHB—kidney cancer	3.74e-05	0.000354	CbGpPWpGaD
Estropipate—CYP1A2—Biological oxidations—POMC—kidney cancer	3.73e-05	0.000353	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	3.73e-05	0.000353	CbGpPWpGaD
Estropipate—ALB—Transmembrane transport of small molecules—SLC5A5—kidney cancer	3.72e-05	0.000352	CbGpPWpGaD
Estropipate—ALB—Metabolism—CA2—kidney cancer	3.71e-05	0.000351	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—AKAP13—kidney cancer	3.62e-05	0.000343	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—CASP2—kidney cancer	3.62e-05	0.000343	CbGpPWpGaD
Estropipate—ALB—Metabolism—ALAD—kidney cancer	3.62e-05	0.000342	CbGpPWpGaD
Estropipate—ALB—Platelet activation, signaling and aggregation—RAF1—kidney cancer	3.6e-05	0.000341	CbGpPWpGaD
Estropipate—ALB—Transmembrane transport of small molecules—SLC2A1—kidney cancer	3.6e-05	0.00034	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—CRABP1—kidney cancer	3.57e-05	0.000338	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—GLIPR1—kidney cancer	3.57e-05	0.000338	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—PPAT—kidney cancer	3.57e-05	0.000338	CbGpPWpGaD
Estropipate—ESR1—Gene Expression—JUNB—kidney cancer	3.56e-05	0.000337	CbGpPWpGaD
Estropipate—ALB—Metabolism—ST3GAL2—kidney cancer	3.53e-05	0.000334	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	3.53e-05	0.000334	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—CCBL1—kidney cancer	3.52e-05	0.000333	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	3.49e-05	0.00033	CbGpPWpGaD
Estropipate—ALB—Metabolism—ALDH1A1—kidney cancer	3.45e-05	0.000326	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—ACY1—kidney cancer	3.4e-05	0.000322	CbGpPWpGaD
Estropipate—ALB—Hemostasis—IGF2—kidney cancer	3.37e-05	0.000319	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—ITPR2—kidney cancer	3.32e-05	0.000314	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—APRT—kidney cancer	3.32e-05	0.000314	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—FH—kidney cancer	3.32e-05	0.000314	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—GRB7—kidney cancer	3.31e-05	0.000313	CbGpPWpGaD
Estropipate—ALB—Metabolism—SLC5A3—kidney cancer	3.31e-05	0.000313	CbGpPWpGaD
Estropipate—ALB—Metabolism—PGK1—kidney cancer	3.31e-05	0.000313	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	3.25e-05	0.000307	CbGpPWpGaD
Estropipate—ALB—Metabolism—LDHB—kidney cancer	3.24e-05	0.000307	CbGpPWpGaD
Estropipate—ALB—Platelet activation, signaling and aggregation—IL2—kidney cancer	3.23e-05	0.000305	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	3.18e-05	0.000301	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—GPC3—kidney cancer	3.12e-05	0.000295	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—ITPR2—kidney cancer	3.08e-05	0.000291	CbGpPWpGaD
Estropipate—SLC22A1—Neuronal System—MAPK1—kidney cancer	3.06e-05	0.00029	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—PPAT—kidney cancer	3.05e-05	0.000289	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—GLIPR1—kidney cancer	3.05e-05	0.000289	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—CA2—kidney cancer	3.04e-05	0.000287	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—GSTT1—kidney cancer	3.03e-05	0.000287	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—ACHE—kidney cancer	3.03e-05	0.000287	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	3.01e-05	0.000285	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	2.98e-05	0.000282	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—ALAD—kidney cancer	2.96e-05	0.00028	CbGpPWpGaD
Estropipate—ESR1—Gene Expression—CDKN2B—kidney cancer	2.9e-05	0.000274	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—PDHB—kidney cancer	2.89e-05	0.000273	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—ST3GAL2—kidney cancer	2.89e-05	0.000273	CbGpPWpGaD
Estropipate—CYP3A4—Biological oxidations—POMC—kidney cancer	2.88e-05	0.000273	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—SCARB1—kidney cancer	2.87e-05	0.000271	CbGpPWpGaD
Estropipate—ALB—Transmembrane transport of small molecules—ABCB1—kidney cancer	2.84e-05	0.000269	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—PTGS1—kidney cancer	2.84e-05	0.000269	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—FH—kidney cancer	2.84e-05	0.000269	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—APRT—kidney cancer	2.84e-05	0.000269	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—ALDH1A1—kidney cancer	2.82e-05	0.000267	CbGpPWpGaD
Estropipate—ALB—Metabolism—CA9—kidney cancer	2.81e-05	0.000266	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—CTNNA1—kidney cancer	2.79e-05	0.000264	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—PSMD7—kidney cancer	2.78e-05	0.000263	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—EIF4EBP1—kidney cancer	2.77e-05	0.000263	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—HSPB1—kidney cancer	2.77e-05	0.000263	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	2.77e-05	0.000262	CbGpPWpGaD
Estropipate—ALB—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	2.75e-05	0.00026	CbGpPWpGaD
Estropipate—ALB—Platelet activation, signaling and aggregation—VEGFA—kidney cancer	2.74e-05	0.00026	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—CCBL1—kidney cancer	2.72e-05	0.000257	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—PGK1—kidney cancer	2.71e-05	0.000256	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—SLC5A3—kidney cancer	2.71e-05	0.000256	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—GPC3—kidney cancer	2.67e-05	0.000252	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—LDHB—kidney cancer	2.65e-05	0.000251	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—BCHE—kidney cancer	2.64e-05	0.00025	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—SLC5A5—kidney cancer	2.61e-05	0.000247	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—CA2—kidney cancer	2.6e-05	0.000246	CbGpPWpGaD
Estropipate—ALB—Platelet activation, signaling and aggregation—MAPK3—kidney cancer	2.6e-05	0.000246	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—PSMD7—kidney cancer	2.58e-05	0.000244	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—TSC1—kidney cancer	2.58e-05	0.000244	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—ANXA1—kidney cancer	2.58e-05	0.000244	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—ALAD—kidney cancer	2.53e-05	0.000239	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—SLC2A1—kidney cancer	2.52e-05	0.000238	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—FLT1—kidney cancer	2.5e-05	0.000236	CbGpPWpGaD
Estropipate—ALB—Platelet activation, signaling and aggregation—MAPK1—kidney cancer	2.47e-05	0.000234	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—ST3GAL2—kidney cancer	2.47e-05	0.000234	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—ALDH1A1—kidney cancer	2.41e-05	0.000228	CbGpPWpGaD
Estropipate—SLC22A1—Transmembrane transport of small molecules—RAF1—kidney cancer	2.4e-05	0.000227	CbGpPWpGaD
Estropipate—ALB—Metabolism—CRABP1—kidney cancer	2.39e-05	0.000226	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—GLIPR1—kidney cancer	2.36e-05	0.000223	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—PPAT—kidney cancer	2.36e-05	0.000223	CbGpPWpGaD
Estropipate—ESR1—Generic Transcription Pathway—MYC—kidney cancer	2.33e-05	0.000221	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—JUNB—kidney cancer	2.32e-05	0.000219	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—PAK1—kidney cancer	2.32e-05	0.000219	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—PGK1—kidney cancer	2.31e-05	0.000219	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—SLC5A3—kidney cancer	2.31e-05	0.000219	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—CA9—kidney cancer	2.3e-05	0.000218	CbGpPWpGaD
Estropipate—ESR2—Gene Expression—MAPK3—kidney cancer	2.29e-05	0.000217	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—LDHB—kidney cancer	2.27e-05	0.000215	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	2.25e-05	0.000213	CbGpPWpGaD
Estropipate—ESR2—Gene Expression—MYC—kidney cancer	2.23e-05	0.000211	CbGpPWpGaD
Estropipate—ALB—Metabolism—ITPR2—kidney cancer	2.22e-05	0.00021	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—FH—kidney cancer	2.19e-05	0.000207	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—APRT—kidney cancer	2.19e-05	0.000207	CbGpPWpGaD
Estropipate—ALB—Platelet activation, signaling and aggregation—PIK3CA—kidney cancer	2.14e-05	0.000203	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—GSTP1—kidney cancer	2.1e-05	0.000199	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—GPC3—kidney cancer	2.06e-05	0.000195	CbGpPWpGaD
Estropipate—ALB—Metabolism of lipids and lipoproteins—POMC—kidney cancer	2.05e-05	0.000194	CbGpPWpGaD
Estropipate—ALB—Metabolism—GSTT1—kidney cancer	2.03e-05	0.000192	CbGpPWpGaD
Estropipate—ALB—Metabolism—ACHE—kidney cancer	2.03e-05	0.000192	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—CA2—kidney cancer	2e-05	0.00019	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—ABCB1—kidney cancer	1.99e-05	0.000188	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—CA9—kidney cancer	1.97e-05	0.000186	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—CRABP1—kidney cancer	1.96e-05	0.000185	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—ALAD—kidney cancer	1.95e-05	0.000185	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—GSTM1—kidney cancer	1.93e-05	0.000183	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	1.92e-05	0.000182	CbGpPWpGaD
Estropipate—ALB—Metabolism—SCARB1—kidney cancer	1.92e-05	0.000182	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—ST3GAL2—kidney cancer	1.91e-05	0.00018	CbGpPWpGaD
Estropipate—ALB—Metabolism—PTGS1—kidney cancer	1.9e-05	0.00018	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—IGF2—kidney cancer	1.89e-05	0.000179	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—CDKN2B—kidney cancer	1.88e-05	0.000178	CbGpPWpGaD
Estropipate—ALB—Metabolism—PSMD7—kidney cancer	1.86e-05	0.000176	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—ALDH1A1—kidney cancer	1.86e-05	0.000176	CbGpPWpGaD
Estropipate—ALB—Hemostasis—RAF1—kidney cancer	1.86e-05	0.000176	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—IGF1R—kidney cancer	1.83e-05	0.000173	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—CYP1A1—kidney cancer	1.83e-05	0.000173	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—ITPR2—kidney cancer	1.82e-05	0.000172	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—SLC5A3—kidney cancer	1.79e-05	0.000169	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—PGK1—kidney cancer	1.79e-05	0.000169	CbGpPWpGaD
Estropipate—ALB—Metabolism—BCHE—kidney cancer	1.77e-05	0.000167	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—LDHB—kidney cancer	1.75e-05	0.000166	CbGpPWpGaD
Estropipate—ALB—Metabolism—SLC5A5—kidney cancer	1.74e-05	0.000165	CbGpPWpGaD
Estropipate—ALB—Metabolism—SLC2A1—kidney cancer	1.68e-05	0.000159	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.68e-05	0.000159	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—CRABP1—kidney cancer	1.67e-05	0.000158	CbGpPWpGaD
Estropipate—ALB—Hemostasis—IL2—kidney cancer	1.66e-05	0.000157	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—GSTT1—kidney cancer	1.66e-05	0.000157	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—ACHE—kidney cancer	1.66e-05	0.000157	CbGpPWpGaD
Estropipate—ALB—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.63e-05	0.000155	CbGpPWpGaD
Estropipate—ALB—Transmembrane transport of small molecules—RAF1—kidney cancer	1.61e-05	0.000152	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—SCARB1—kidney cancer	1.57e-05	0.000149	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—ITPR2—kidney cancer	1.55e-05	0.000147	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—PTGS1—kidney cancer	1.55e-05	0.000147	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—PSMD7—kidney cancer	1.52e-05	0.000144	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—CA9—kidney cancer	1.52e-05	0.000144	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—HIF1A—kidney cancer	1.51e-05	0.000143	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—TSC2—kidney cancer	1.5e-05	0.000142	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—BCHE—kidney cancer	1.45e-05	0.000137	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—KDR—kidney cancer	1.44e-05	0.000136	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.43e-05	0.000136	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—SLC5A5—kidney cancer	1.43e-05	0.000135	CbGpPWpGaD
Estropipate—ALB—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.43e-05	0.000135	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—ACHE—kidney cancer	1.42e-05	0.000134	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—GSTT1—kidney cancer	1.42e-05	0.000134	CbGpPWpGaD
Estropipate—ALB—Hemostasis—VEGFA—kidney cancer	1.41e-05	0.000134	CbGpPWpGaD
Estropipate—ALB—Metabolism—GSTP1—kidney cancer	1.4e-05	0.000133	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—SLC2A1—kidney cancer	1.38e-05	0.00013	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—POMC—kidney cancer	1.36e-05	0.000129	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—SCARB1—kidney cancer	1.34e-05	0.000127	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.34e-05	0.000127	CbGpPWpGaD
Estropipate—ALB—Hemostasis—MAPK3—kidney cancer	1.34e-05	0.000127	CbGpPWpGaD
Estropipate—ALB—Metabolism—ABCB1—kidney cancer	1.33e-05	0.000126	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—PTGS1—kidney cancer	1.33e-05	0.000126	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—KIT—kidney cancer	1.33e-05	0.000126	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—APC—kidney cancer	1.33e-05	0.000126	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—PSMD7—kidney cancer	1.3e-05	0.000123	CbGpPWpGaD
Estropipate—ALB—Metabolism—GSTM1—kidney cancer	1.29e-05	0.000122	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—CRABP1—kidney cancer	1.29e-05	0.000122	CbGpPWpGaD
Estropipate—ALB—Hemostasis—MAPK1—kidney cancer	1.27e-05	0.00012	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—POMC—kidney cancer	1.26e-05	0.00012	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—BRAF—kidney cancer	1.25e-05	0.000118	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—BCHE—kidney cancer	1.24e-05	0.000117	CbGpPWpGaD
Estropipate—ALB—Metabolism—CYP1A1—kidney cancer	1.22e-05	0.000116	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—SLC5A5—kidney cancer	1.22e-05	0.000115	CbGpPWpGaD
Estropipate—ALB—Hemostasis—KRAS—kidney cancer	1.2e-05	0.000114	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—ITPR2—kidney cancer	1.2e-05	0.000114	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—SLC2A1—kidney cancer	1.18e-05	0.000111	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.17e-05	0.00011	CbGpPWpGaD
Estropipate—ESR1—Gene Expression—MAPK3—kidney cancer	1.16e-05	0.000109	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—GSTP1—kidney cancer	1.15e-05	0.000109	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.14e-05	0.000108	CbGpPWpGaD
Estropipate—ESR1—Gene Expression—MYC—kidney cancer	1.12e-05	0.000106	CbGpPWpGaD
Estropipate—ALB—Hemostasis—PIK3CA—kidney cancer	1.1e-05	0.000105	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—GSTT1—kidney cancer	1.09e-05	0.000104	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—ACHE—kidney cancer	1.09e-05	0.000104	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—ABCB1—kidney cancer	1.09e-05	0.000103	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—PTGS2—kidney cancer	1.09e-05	0.000103	CbGpPWpGaD
Estropipate—ALB—Hemostasis—TP53—kidney cancer	1.07e-05	0.000101	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—GSTM1—kidney cancer	1.06e-05	0.0001	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—RAF1—kidney cancer	1.04e-05	9.86e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—RELA—kidney cancer	1.04e-05	9.82e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—SCARB1—kidney cancer	1.04e-05	9.8e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—ERBB2—kidney cancer	1.03e-05	9.75e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—PTGS1—kidney cancer	1.03e-05	9.7e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—MTOR—kidney cancer	1.02e-05	9.63e-05	CbGpPWpGaD
Estropipate—ALB—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.01e-05	9.52e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—PSMD7—kidney cancer	1.01e-05	9.51e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—CYP1A1—kidney cancer	1e-05	9.48e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	9.97e-06	9.43e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—GSTP1—kidney cancer	9.83e-06	9.3e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—CDKN1B—kidney cancer	9.55e-06	9.03e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—BCHE—kidney cancer	9.53e-06	9.02e-05	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—PTEN—kidney cancer	9.49e-06	8.98e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—SLC5A5—kidney cancer	9.42e-06	8.91e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—IL2—kidney cancer	9.34e-06	8.84e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—ABCB1—kidney cancer	9.3e-06	8.8e-05	CbGpPWpGaD
Estropipate—ALB—Metabolism—POMC—kidney cancer	9.13e-06	8.64e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—CCND1—kidney cancer	9.11e-06	8.62e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—SLC2A1—kidney cancer	9.09e-06	8.6e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—JUN—kidney cancer	9.09e-06	8.6e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—GSTM1—kidney cancer	9.03e-06	8.55e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—CTNNB1—kidney cancer	9.02e-06	8.53e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—PTEN—kidney cancer	8.79e-06	8.32e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—CYP1A1—kidney cancer	8.56e-06	8.1e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	8.23e-06	7.79e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—VEGFA—kidney cancer	7.94e-06	7.51e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—GSTP1—kidney cancer	7.58e-06	7.18e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—MAPK3—kidney cancer	7.51e-06	7.11e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—POMC—kidney cancer	7.47e-06	7.07e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—MYC—kidney cancer	7.3e-06	6.91e-05	CbGpPWpGaD
Estropipate—ALB—Metabolism—PTGS2—kidney cancer	7.28e-06	6.89e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—ABCB1—kidney cancer	7.18e-06	6.79e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—MAPK1—kidney cancer	7.15e-06	6.76e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	7.03e-06	6.66e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—GSTM1—kidney cancer	6.97e-06	6.6e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—KRAS—kidney cancer	6.75e-06	6.39e-05	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—PIK3CA—kidney cancer	6.69e-06	6.33e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—CYP1A1—kidney cancer	6.61e-06	6.25e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—POMC—kidney cancer	6.38e-06	6.04e-05	CbGpPWpGaD
Estropipate—ALB—Metabolism—PTEN—kidney cancer	6.35e-06	6.01e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—PIK3CA—kidney cancer	6.2e-06	5.87e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—TP53—kidney cancer	6e-06	5.68e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—PTGS2—kidney cancer	5.96e-06	5.64e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—PTEN—kidney cancer	5.2e-06	4.92e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—PTGS2—kidney cancer	5.09e-06	4.82e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—POMC—kidney cancer	4.93e-06	4.66e-05	CbGpPWpGaD
Estropipate—ALB—Metabolism—PIK3CA—kidney cancer	4.48e-06	4.24e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—PTEN—kidney cancer	4.44e-06	4.2e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—PTGS2—kidney cancer	3.93e-06	3.72e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—PIK3CA—kidney cancer	3.67e-06	3.47e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—PTEN—kidney cancer	3.43e-06	3.24e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—PIK3CA—kidney cancer	3.13e-06	2.96e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—PIK3CA—kidney cancer	2.42e-06	2.29e-05	CbGpPWpGaD
